Getty Images

Q and A with the experts: AstraZeneca and viral vector vaccines

Posted on

The AstraZeneca vaccine has recently been approved in Canada and is evaluated to be about 62 per cent effective in preventing the COVID-19 virus.

Kelly Grindrod, a pharmacist and professor, breaks down how this vaccine and others like it work.

https://uwaterloo.ca/news/media/q-and-experts-astrazeneca-and-viral-vector-vaccines

Read More Impact Stories

Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Posted on
UBC’s Dr. James Lim is part of a research team helping to bring new hope to children battling hard-to-treat cancers. [...]